Wilson's disease with hepatic presentation in childhood

A Yüce1, N Kocak, F Gürakan

  • 1Division of Gastroenterology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkiye. haozen@hacettepe.edu.tp

Indian Pediatrics
|April 4, 2000
PubMed

Insights

Wilson's disease in children often presents with liver issues. Early diagnosis and consistent treatment are crucial for managing this genetic disorder and preventing severe outcomes like liver failure.

Area of Science:

  • Pediatric Hepatology
  • Genetic Metabolic Disorders
  • Clinical Medicine

Background:

  • Wilson's disease is a rare genetic disorder of copper metabolism.
  • Hepatic presentation is common in pediatric Wilson's disease, often leading to significant morbidity.
  • Timely diagnosis and management are critical to prevent irreversible liver damage.

Purpose of the Study:

  • To analyze the clinical features, diagnostic methods, treatment strategies, and long-term outcomes of pediatric Wilson's disease with a primary hepatic presentation.
  • To identify key indicators for early diagnosis and predict prognosis in affected children.

Main Methods:

  • A retrospective study was conducted at a university medical center.
  • Data from 34 children diagnosed with Wilson's disease (hepatic presentation) over 18 years were analyzed.
  • Diagnosis relied on family history, Kayser-Fleischer rings, low serum ceruloplasmin, and elevated copper in urine and liver tissue.

Main Results:

  • Common symptoms included abdominal pain and distension; hepatomegaly and elevated transaminases were frequent findings.
  • Eight patients presented with fulminant hepatic failure, and 20 had cirrhosis.
  • Treatment involved D-penicillamine and zinc sulfate; 3 patients received liver transplants. Long-term follow-up revealed that poor compliance correlated with disease progression.

Conclusions:

  • Wilson's disease should be strongly suspected in children with unexplained liver disease, particularly with a positive family history or parental consanguinity.
  • Consistent adherence to treatment is vital for long-term stability and preventing decompensated cirrhosis.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...